Texting your doctor: a simple app could save lives after lung screening

NCT ID NCT07234929

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether using a chat-based mobile app (Zalo) can help people follow through with recommended tests after an abnormal chest X-ray read by AI. About 2,692 adults in Vietnam at risk for lung cancer or TB will be randomly assigned to receive either standard results or extra chat-based guidance and doctor access. The goal is to see if digital support boosts follow-up rates and speeds up diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
chat-based mobile application (Zalo) for consultation and education
What this could lead to
If successful, this could provide a low-cost, scalable way to improve follow-up after lung disease screening, leading to earlier diagnosis and treatment of lung cancer and TB.
What could go wrong
This is a single-center trial in Vietnam, so results may not apply elsewhere. It relies on patients having a smartphone and Zalo account, and compliance is self-reported, which may be inaccurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE IN RADIOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nhan Dan Gia Dinh Hospital

    Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.